This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taejeon-si, KR (2009 - 2011)
- Seoul, KR (2012)
Company Filing History:
Years Active: 2009-2012
Title: Innovations of Jong-Shin Yoo in Cancer Diagnosis
Introduction
Jong-Shin Yoo is a prominent inventor based in Taejeon-si, South Korea. He has made significant contributions to the field of bioscience and biotechnology, particularly in the diagnosis of cancers. With a total of three patents to his name, his work focuses on innovative methods for analyzing glycoproteins and their role in tumorigenesis.
Latest Patents
Jong-Shin Yoo's latest patents include an identification method of glycoproteins using specific lectin precipitation. This invention relates to an analyzing method that measures the changes of glycosylation in various glycoproteins involved in tumorigenesis and metastasis. Another notable patent is a method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis, along with a diagnostic kit utilizing this method. This invention is particularly effective for diagnosing cancers such as colon cancer, stomach cancer, lung cancer, and liver cancer.
Career Highlights
Jong-Shin Yoo is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he continues to advance research in cancer diagnostics. His innovative approaches have the potential to significantly improve the sensitivity and accuracy of cancer detection.
Collaborations
Some of his notable coworkers include Jeong Heon Ko and Soo Young Hwang, who contribute to the collaborative efforts in their research projects.
Conclusion
Jong-Shin Yoo's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer diagnosis. His patents reflect a commitment to improving diagnostic methods, which can lead to better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
